Alnylam Pharmaceuticals
ALNY
#1098
Rank
ยฃ15.88 B
Marketcap
ยฃ118.57
Share price
-2.02%
Change (1 day)
-66.13%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

ESG Reports

Thumbnail Alnylam Pharmaceuticals
 ESG Report 2025

ESG Report 2025

Language: English

View ESG Report
Thumbnail Alnylam Pharmaceuticals
 ESG Report 2024

ESG Report 2024

Language: English

View ESG Report